v3.25.2
Segment Information
 6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
Engineered
Materials		Acetyl ChainOther
Activities		EliminationsConsolidated
(In $ millions)
Three Months Ended June 30, 2025
Net sales1,442 1,115 — (25)(1)2,532 
Cost of sales(1,097)(925)— 25 (1,997)
Gross profit345 190 — — 535 
Selling, general and administrative expenses(100)(23)(90)— (213)
Amortization of intangible assets(41)(1)— — (42)
Research and development expenses(21)(10)— — (31)
Other (charges) gains, net (Note 18)
(16)(1)(3)— (20)
Gain (loss) on disposition of business and assets, net(2)(1)1 — (2)
Other segment items(2)
— — 6 — 6 
Operating profit (loss)165 154 (86)— 233 
Depreciation and amortization
114 64 12 — 190 
Equity in net earnings (loss) of affiliates
24 2 3 — 29 
Capital expenditures46 32 6 — 84 (3)
Three Months Ended June 30, 2024
Net sales1,467 1,202 — (18)(1)2,651 
Cost of sales(1,110)(919)1 18 (2,010)
Gross profit357 283 1 — 641 
Selling, general and administrative expenses(109)(28)(118)— (255)
Amortization of intangible assets(38)— — — (38)
Research and development expenses(23)(10)— — (33)
Other (charges) gains, net (Note 18)
(43)(1)(4)— (48)
Gain (loss) on disposition of business and assets, net(6)(2)— — (8)
Other segment items(2)
— — (9)— (9)
Operating profit (loss)138 242 (130)— 250 
Depreciation and amortization
121 61 10 — 192 
Equity in net earnings (loss) of affiliates
47 3 1 — 51 
Capital expenditures41 36 10 — 87 (3)
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes Foreign exchange gain (loss), net.
(3)Includes a decrease in accrued capital expenditures of $9 million and $18 million for the three months ended June 30, 2025 and 2024, respectively.
Engineered
Materials		Acetyl ChainOther
Activities		EliminationsConsolidated
(In $ millions)
Six Months Ended June 30, 2025
Net sales2,729 2,231 — (39)(1)4,921 
Cost of sales(2,109)(1,839)(1)39 (3,910)
Gross profit620 392 (1)— 1,011 
Selling, general and administrative expenses(207)(50)(186)— (443)
Amortization of intangible assets(81)(1)— — (82)
Research and development expenses(42)(20)— — (62)
Other (charges) gains, net (Note 18)
(31)(4)(16)— (51)
Gain (loss) on disposition of business and assets, net2 (1)— — 1 
Other segment items(2)
— — 27 — 27 
Operating profit (loss)261 316 (176)— 401 
Depreciation and amortization
223 125 22 — 370 
Equity in net earnings (loss) of affiliates
40 5 6 — 51 
Capital expenditures85 62 15 — 162 (3)
As of June 30, 2025
Goodwill and intangible assets, net8,799 439 — — 9,238 
Total assets15,868 5,488 2,357 — 23,713 
Six Months Ended June 30, 2024
Net sales2,845 2,463 — (46)(1)5,262 
Cost of sales(2,219)(1,885)(9)46 (4,067)
Gross profit626 578 (9)— 1,195 
Selling, general and administrative expenses(212)(58)(250)— (520)
Amortization of intangible assets(78)(1)— — (79)
Research and development expenses(48)(20)1 — (67)
Other (charges) gains, net (Note 18)
(54)(1)(7)— (62)
Gain (loss) on disposition of business and assets, net(7)(2)— — (9)
Other segment items(2)
— — 2 — 2 
Operating profit (loss)227 496 (263)— 460 
Depreciation and amortization
268 118 27 — 413 
Equity in net earnings (loss) of affiliates
96 5 5 — 106 
Capital expenditures78 76 38 — 192 (3)
As of December 31, 2024
Goodwill and intangible assets, net
8,617 411 — — 9,028 
Total assets15,496 5,2652,096 — 22,857 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes Foreign exchange gain (loss), net.
(3)Includes a decrease in accrued capital expenditures of $33 million and $50 million for the six months ended June 30, 2025 and 2024, respectively.